Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
-
-
The Times, They Are a-Changin’
For contract organizations and generics, for sureEmil W. Ciurczak, DoraMaxx Consulting 07.20.18
-
Regulatory Affairs
Elemental Impurity & Risk Assessment
An update on the retirement of USP General Chapter <231>.Paul Mason, Lachman Consultants 07.20.18
-
Interview Success Depends Upon Your Preparation
Some tips on bringing your pre-interview stress levels way downDavid G. Jensen, Contributing Editor 07.20.18
-
Biologics, Proteins, Vaccines | Biosimilars
Biogenerics Progress
Generic makers target big forays into major marketsS. Harachand, Contributing Editor 06.12.18
-
cGMP Manufacture
The Good, The Bad, and The Ugly Complexities of Pharmaceutical Manufacturing
What does it really take to develop, design, scale-up, commercialize and manage continuous processes?Girish Malhotra, Contributing Editor 06.12.18
-
Analytical Services | Bioanalytical Services | Laboratory Testing
The Final Frontier
A look at contract bioprocessing and PAT/QbDEmil W. Ciurczak, DoraMaxx Consulting 06.12.18
-
Information Technology
Putting Data Integrity in Quality Agreements
With growing regulatory scrutiny, sponsors are focusing more on data integrity in supplier quality agreements.Robert Marohn, ClinLogic, LLC 06.12.18
-
Regulatory Affairs | Solid Dosage/Creams/Ointments
Semi-Solid Dosage Forms
Compliance of semi-solid dosages to FDA Stage III Continuous Process VerificationJosé L. Toro, Ph.D., Lachman Consultants 06.12.18
-
Decoding Company Culture: The Key to a Long Term Fit
Having shared and aligned values is critical to success in the workplace.Ryan Raver, PhD w/David G. Jensen 06.12.18
-
The Salary Survey & Much More
From surveys, to drug development & delivery to compliance, the June issue covers a lot of ground06.12.18
-
Regulatory Affairs
India raises bar for clinical trial oversight
New guidelines to bolster institutional ethical committeesS. Harachand, Contributing Editor 05.08.18
-
Opportunities to Lower Drug Prices and Improve Affordability
From creation (manufacturing) to consumption (patient)Girish Malhotra, Contributing Editor 05.08.18
-
-
Analytical Services | Laboratory Testing
We Need to Get Back to Basics
In life, and the lab, the calculator/computer is a blessing and a curse!Emil W. Ciurczak, DoraMaxx Consulting 05.08.18
-
Regulatory Affairs
GDUFA II: Do You Have a Strategy?
Generic companies continue to face multiple challenges in an ever-increasing competitive market placeJanis A. Picurro, Lachman Consultants 05.08.18
-
Core Traits to Take You the Distance
Six attributes recruiters and hiring managers look for in a candidate.David G. Jensen, Contributing Editor 05.08.18
-
CMOs Growing Strong in APIs
Major API players in India continue to invest in operationsS Harachand, Contributing Editor 04.10.18
-
Biologics, Proteins, Vaccines
Innovate UK Grant Supports Viral Vector Manufacturing
Cobra Biologics talks about its recently awarded $3.4 million capital infrastructure investmentBetsy Louda, Associate Editor 04.10.18
